F-star: Takeda, F-star Therapeutics Partner to Advance Immunotherapies
To jointly research and develop antibodies for new immuno-oncology targets leveraging F-star's fully-human Fcab and tetravalent mAb2 platforms.
Read full article »
F-star is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases.
Read more